Kim-Hien Dao
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Kim-Hien Dao is Chief Medical Officer at Electra Therapeutics, Inc. since 2024.
Formerly, Dr. Dao was Executive Medical Director-Clinical Development at Astex Pharmaceuticals, Inc. from 2019 to 2023.
Dr. Dao earned a doctorate from Michigan State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/09/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Directeur Technique/Scientifique/R&D | 01/03/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Health Technology |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national